Gujarat Fluorochemicals Limited share price
NSE: FLUOROCHEM · ISIN INE09N301011
Key numbers
- Market cap
- ₹ 48,789 Cr
- Current price
- ₹ 4,441.40
- 52-week high / low
- ₹ 4,959 / 2,917
- Stock P/E
- 79.4
- Book value
- ₹ 696.7
- Dividend yield
- 0.07%
- ROCE
- 9.2%
- ROE
- 7.6%
- Debt to equity
- 0.29
- Sales growth (3 yrs)
- -4.5%
- Profit growth (3 yrs)
- -24.3%
- 1-year return
- 17.1%
About Gujarat Fluorochemicals Limited
Gujarat Fluorochemicals Limited engages in the manufacture and trading of refrigerant gases, fluorochemicals, fluoropolymers, battery chemicals, wind energy, and renewable energy solutions in India, Europe, the United States, and internationally. It provides caustic soda, carbon tetrachloride, chlorine, methylene di chloride, hydrochloric acid, sodium hydrogen sulphate, hydrogen gas, fluorspar, chloroform, and anhydrous hydrogen chloride. The company offers its products under the INOFLON, FLUONOX, INOFLAR, INOLUB, and Refron brands. It provides its products to agrochemicals, pharmaceuticals, battery materials, and other sectors. It also engages in design, develop, manufacture, export, import, assemble, fit, repair, convert, over-haul, alter, maintain, and improve all types of semiconductor devices, integrated circuits, electronic components, software, devices, technologies, equipment and appliances, and electronic devices. In addition, the company provides PTFE, micro powders, PVDF, FEP, FKM, and PPA; and battery chemicals, including lithium hexafluorophosphate, electrolyte formulations, PVDF and PTFE binders, LFP cathode active material, and additives. The company was formerly…
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 1,281 | 1,210 | 1,136 | 1,369 | 1,588 |
| Operating profit | 325 | 335 | 256 | 286 | 415 |
| Net profit | 184 | 179 | 103 | 112 | 219 |
| EPS (₹) | 16.75 | 16.31 | 9.29 | 9.92 | 20.17 |
Concall summary (2026-08-19)
AI summary of the earnings call transcript · tone: Positive · source document
Guidance & outlook
- On a year -on-year basis, revenue from our Chemical segment increased 23% to INR 1,574 crores, compared to INR 1,281 crores in Q 1 FY26.
- EBITDA margin improved from 26% in Q4 FY26 to 29% in Q1 FY27, reflecting the benefits of higher volumes , improved product mix and operating leverage.
Growth & demand
- Chemical segment EBITDA grew 29% to INR 458 crores from INR 354 crores, while segment PAT increased 33% to INR 261 crores.
- At the consolidated level, revenue increased 16% quarter-on-quarter to INR 1,588 crores, while EBITDA grew 39% to INR 428 crores.
Margins & costs
- EBITDA increased 24% to INR 428 crores, while consolidated PAT stood at INR 219 crores, representing 19% growth over the same period last year.
- Within the Chemical segment, revenue grew 16% quarter -on-quarter to INR 1,574 crores, while EBITDA increased 30% to INR 458 crores.
Capex & expansion
- With existing capacity utilization already at peak levels, this expansion will enhance our ability to participate in the growing global R32 market and support future demand growth.
- In LiPF6 salt, we are advancing both capacity expansion and customer commercialization efforts with leading global electrolyte manufacturers.
Balance sheet & cash
- Healthy demand across key product categories, disciplined execution and improving operating leverage enabled us to deliver broad-based growth across our core chemical businesses.
- Our focus on working capital efficiency has also yielded strong results with working capital days reducing by 43 days to 149 days as of Q1 FY27 compared to 192 days as of Q4 FY26.
Peers in Specialty Chemicals
Data for information only, not investment advice. Prices end of day.